Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3720-3727

  Welt, Corrine K ^a   Lambert Messerlian, Geralyn ^b   Zheng, Wenxin ^c   Crowley Jr , William F ^a   Schneyer, Alan L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; CA 125 ANTIGEN; FOLLISTATIN; INHIBIN; MESSENGER RNA; THYMIDINE; TRITIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL;

TRITIUM;

EID: 0030670883     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.11.3720     Document Type: Article

References (50)

1. Richardson GS, Scully RE, Nikrui N, Nelson, Jr, JH. 1985 Common epithelial cancer of the ovary. N Engl J Med. 312:415-423.
2. Weiss NS, Homonchuk T, Young JLJ. 1977 Incidence of the histologic types of ovarian cancer: the U.S. Third National Cancer Survey, 1969-1977. Gynecol Oncol. 5:161-167.
3. Shoham Z. 1994 Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: where are we today? Fertil Steril. 62:433-448.
4. Whittemore AS, Harris R, Itnyre J. 1992 Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Am J Epidemiol. 136:1184-1203.
5. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. 1994 Ovarian tumors in a cohort of infertile women. N Engl J Med. 331:771-776.
6. Vale W, Rivier C, Hsueh A, et al. 1988 Chemical and biological characterization of the inhibin family of protein hormones. Rec Prog Horm Res. 44:1-34.
7. Zheng W, Sung CJ, Hanna I, Lambert-Messerlian G, Steinhoff M, Lauchlan SC. 1997 α and β subunits of inhibin / activin as markers for gonadal sex-cord stromal differentiation. Int J Gyn Pathol. in press.
8. Ohashi M, Hasegawa Y, Haji M, Igarashi M, Nawata H. 1990 Production of immunoreactive inhibin by a virilizing ovarian tumour (sertoli-leydig tumour). Clin Endocrinol (Oxf). 33:613-618.
9. Puls LE, Hamous J, Morrow MS, Schneyer A, MacLaughlin DT, Castracane VD. 1994 Recurrent ovarian sex cord tumor with annular tubules: tumor marker and chemotherapy experience. Gynecol Oncol. 54:396-401.
10. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, deBruijn WA. 1989 Inhibin as a marker for granulosa-cell tumors. N Engl J Med. 321:790-793.
11. Cooke I, O'Brien MO, Charnock FM, Groome N, Ganesan TS. 1995 Inhibin as a marker for ovarian cancer. Br J Cancer. 71:1046-1050.
12. Burger HG, Fuller PJ. 1996 The inhibin / activin family in ovarian cancer. Trends Endocrinol Metab. 7:197-202.
13. Healy DL, Burger HG, Mamers P, et al. 1993 Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med. 18:1539-1542.
14. Matzuk MM, Finegold MJ, Su JJ, Hsueh AJW, Bradley A. 1992 Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 360:313-319.
15. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu L, Bradley A. 1994 Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Nat Acad Sci USA. 91:8817-8821.
16. Di Simone N, Crowley WF, Wang QF, Sluss PM, Schneyer AL. 1996 Characterization of inhibin / activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology. 137:486-494.
17. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. 1990 Activinbinding protein from rat ovary is follistatin. Science. 247:836-838.
18. Kogawa K, Nakamura T, Sugino K, Takio K, Titani K, Sugino H. 1991 Activin-binding protein is present in pituitary. Endocrinology. 128:1434-1440.
19. Schneyer A, Rzucidlo DA, Sluss PM, Crowley, Jr, WF. 1994 Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology. 135:667-674.
20. Shikone T, Matzuk MM, Perlas E, et al. 1994 Characterization of gonadal sex cord-stromal tumor cell lines from inhibin alpha and p53-deficient mice: the role of activin as an autocrine growth factor. Mol Endocrinol. 8:983-995.
21. Owens RB, Smith HS, Nelson-Rees WA, Springer EC. 1976 Epithelial cell cultures from normal and cancerous human tissues. J Natl Cancer Inst. 56:843-849.
22. Kruk PA, Maines-Bandiera SL, Auersperg N. 1990 A simplified method to culture human ovarian surface epithelium. Lab Invest. 63:132-136.
23. Ioachim HL, Sabbath M, Andersson B, Barber HRK. 1974 Tissue cultures of ovarian carcinomas. Lab Invest. 31:381-390.
24. Auersperg N, Siemens CH, Myrdal SE. 1984 Human ovarian surface epithelium in primary culture. In Vitro. 20:743-755.
25. Filicori M, Santoro M, Merriam GR, Crowley, Jr, WF. 1986 Characterization of the physiologic pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab. 62:1136-1144.
26. Muttukrishna S, Fowler PA, George L, Groome NP, Knight PG. 1996 Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab. 81:3328-3334.
27. Schneyer AL, Mason AJ, Burton LE, Ziegner JR, Crowley WF. 1990 Immunoreactive inhibin alpha subunit in human serum: implications for RIA. J Clin Endocrinol Metab. 70:1208-1212.
28. Lambert-Messerlian GM, Isaacson K, Crowley WFJ, Sluss P, Schneyer AL. 1994 Human follicular fluid contains pro-and C-terminal immunoreactive alpha-inhibin precursor proteins. J Clin Endocrinol Metab. 78:433-39.
29. Lambert-Messerlian GM, Hall JE, Sluss PM, et al. 1994 Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab. 79:45-50.
30. Knight PG, Muttukrishna S, Groome NP. 1996 Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol. 148:267-279.
31. Wang QF, Khoury RH, Smith PC, et al. 1996 A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-cell line (PA-1). J Clin Endocrinol Metab. 81:1434-1441.
32. Khoury RH, Wang QF, Crowley WF, et al. 1995 Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin. J Clin Endocrinol Metab. 80:1361-1368.
33. Di Simone N, Hall HA, Schneyer AL. 1996 Activin regulates βA and activin receptor mRNA in an activin responsive testicular tumor (TT) cell line. 10th International Congress of Endocrinology, San Francisco, CA, P3-267.
34. Mason AJ, Niall HD, Seeburg PH. 1986 Structure of two human ovarian inhibins. Biochem Biophys Res Comm. 135:957-964.
35. Cross M, Dexter TM. 1991 Growth factors in development, transformation, and tumorigenesis. Cell. 64:271-280.
36. Roberts VJ, Barth S, El-Roeiy A, Yen SS. 1993 Expression of inhibin / activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab. 77:1402-1410.
37. DePaolo LV, Bicsak TA, Erickson GF, Shimasaki S, Ling N. 1991 Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Med. 198:500-512.
38. Gurusinghe CJ, Healy DL, Jobling T, Mamers P, Burger HG. 1995 Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol. 57:27-32.
39. Li R, Phillips DM, Mather JP. 1995 Activin promotes ovarian follicle development. Endocrinology. 136:849-856.
40. Rabinovici J, Spencer SJ, Jaffe RB. 1990 Recombinant human activin-A promotes proliferation of human luteinized preovulatory granulosa cells in vitro. J Clin Endocrinol Metab. 71:1396-1398.
41. Tsao S, Mok SC, Fey EG, et al. 1995 Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6 ORFs). Exp Cell Res. 218:499-507.
42. Hurteau J, Rodriquez GC, Whitaker RS, et al. 1994 Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer. 74:93-99.
43. Murphy ED. 1966 Characteristic Tumors. In: Green EL, ed. Biology of the laboratory mouse. New York: McGraw-Hill Book Company; 521-562.
44. Mayo KE, Cerelli GM, Spiess J, et al. 1986 Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc Nat Acad Sci USA. 83:5849-5853.
45. Mason AJ. 1988 Structure and recombinant expression of human inhibin and activin. In: Hodgen GD, Rosenwaks Z, Spieler JM, eds. Non-steroidal gonadal factors. Norfolk, VA: Jones Institute Press; 15-21.
46. Shimasaki S, Koga M, Esch F, et al. 1988 Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci USA. 85-4218-4222.
47. Dijke PT, Ichijo H, Franzen P, et al. 1993 Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine / threonine kinase activity. Oncogene. 8:2879-2887.
48. Donaldson CJ, Mathews LM, Vale WW. 1992 Molecular cloning and binding properties of the human type II activin receptor. Biochem Biophys Res Comm. 184:310-316.
49. Hilden K, Tuuri T, Eramaa M, Ritvos O. 1994 Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor. Blood. 83:2163-2170.
50. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. 1984 Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 12:1687-1696.